SITAGLIPTIN Metformin Mepha 50/1000mg 196 pce

7680683780067 CH-68378 A10BD07 07.06.2.

Reimbursement limitations:

JANUMET3

Pour le traitement des patients diabétiques de type 2 qui ne peuvent pas être suffisamment …

SITAGLIPTIN Metformin Mepha 50/1000mg 196 pce
SITAGLIPTIN Metformin Mepha 50/1000mg 196 pce
SITAGLIPTIN Metformin Mepha 50/1000mg 196 pce
1 / 3
google

Details

Product number
6837803
CPT
-
Packaging group
196
Unit
Tablette(n)
Composition
metformini hydrochloridum 1000 mg, sitagliptinum 50 mg ut sitagliptini hydrochloridum monohydricum, cellulosum microcristallinum, povidonum K 29-32, natrii laurilsulfas, natrii stearylis fumaras, Überzug: copolymerum macrogolo et alcoholi poly(vinylico) constatum, talcum, glyceroli monocaprylocapras, poly(alcohol vinylicus), E 171, E 172 (rubrum), E 172 (nigrum), pro compresso obducto corresp. natrium 2.05 mg.

Articles (1)

Sitagliptin-Metformin-Mepha 50/1000 mg, Filmtabletten
Filmtabletten
196
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
07/06/2024
Professional SmPC
Français
07/06/2024
Patient information leaflet
Allemand
06/06/2024
Patient information leaflet
Français
06/06/2024
Patient information leaflet
Italien
06/06/2024

Detailed composition

Substance Quantity Type Category
(N/A)
1000.0 MG Substance Wirkstoff (Principe actif)
(N/A)
50.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
natrii laurilsulfas
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance FTODK
(N/A)
2.05 MG Substance HBESI

Reimbursement information

Public price
CHF 52.60
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/05/2023

Authorization holder

Mepha Pharma AG

4051 Basel

Authorization information

Swissmedic authorization number
68378
Drug name
Sitagliptin-Metformin-Mepha, Filmtabletten
Galenic form
FILM
ATC Code
A10BD07
Authorization status
Z
Dispensation category
B
First authorization
05/04/2022
Authorization expiration date
04/04/2027
IT number
07.06.2.
Domain
Human medicine
Field of application
Diabetes Typ 2

Packaging details

Description (FR)
SITAGLIPTIN Metformin Mepha 50/1000mg 196 pce
Description (DE)
SITAGLIPTIN Metformin Mepha 50/1000mg 196 Stk
Market launch
05/04/2022
Narcotic (BTM)
No

Original drug

Janumet, Filmtabletten
CHF 41.30
View original

Other packaging sizes

SITAGLIPTIN Metformin Mepha 50/500mg 56 pce
56 TABL
View
SITAGLIPTIN Metformin Mepha 50/500mg 196 pce
196 TABL
View
SITAGLIPTIN Metformin Mepha 50/850mg 56 pce
56 TABL
View
SITAGLIPTIN Metformin Mepha 50/850mg 196 pce
196 TABL
View
SITAGLIPTIN Metformin Mepha 50/850mg bte 100 pce
100 TABL
View
SITAGLIPTIN Metformin Mepha 50/1000mg 56 pce
56 TABL
View
SITAGLIPTIN Metformin Mepha 50/1000mg bte 100 pce
100 TABL
View